Suppr超能文献

异丙托溴铵与赛洛唑啉局部联合用药治疗急性上呼吸道感染相关流涕和鼻塞症状的疗效与安全性。

Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection.

作者信息

Eccles Ronald, Pedersen Anette, Regberg Dan, Tulento Heikki, Borum Peter, Stjärne Pär

机构信息

Common Cold Centre, Cardiff School of Biosciences, Cardiff University, United Kingdom.

出版信息

Am J Rhinol. 2007 Jan-Feb;21(1):40-5. doi: 10.2500/ajr.2007.21.2902.

Abstract

BACKGROUND

Rhinorrhea and nasal congestion are simultaneous symptoms associated with the common cold. This study investigated the efficacy and safety of a combination nasal spray of ipratropium and xylometazoline for simultaneous treatment of these symptoms.

METHODS

The trial was a multicenter double-blind, parallel-group, randomized design on patients with common cold symptoms. Patients scored symptoms of runny nose and nasal congestion and recorded adverse events in a diary for up to 7 days. Patients also recorded tissue use. The five test treatments consisted of ipratropium, 0.6 mg/mL, and xylometazoline, 1.0 mg/mL; ipratropium, 0.6 mg/mL, and xylometazoline, 0.5 mg/mL; ipratropium, 0.6 mg/mL; xylometazoline, 1.0 mg/mL; and placebo solution.

RESULTS

Eight hundred sixty-four patients were screened and 786 patients received treatment. One day after treatment there was a clear separation between the scores for the placebo and ipratropium treatment groups for rhinorrhea and between the placebo and xylometazoline treatment groups for congestion. Both ipratropium/xylometazoline 1.0 and ipratropium/xylometazoline 0.5 treatments were superior to xylometazoline with respect to rhinorrhea (p < 0.0001) and superior to ipratropium with respect to nasal congestion scores (p < 0.001). Both the ipratropium combination treatments had significantly lower tissue use than the xylometazoline treatment group (p < 0.0001). Adverse events were distributed equally between the treatments, except mucus tinged with blood, epistaxis, nasal passage irritation, and nasal dryness, which had a higher incidence in the three groups that received medicines containing ipratropium.

CONCLUSION

The results indicate that a combination medicine of ipratropium and xylometazoline is safe and effective for treatment of rhinorrhea and nasal congestion associated with common cold.

摘要

背景

流涕和鼻塞是普通感冒的并发症状。本研究调查了异丙托溴铵和赛洛唑啉复方鼻喷雾剂同时治疗这些症状的疗效和安全性。

方法

该试验为针对有普通感冒症状患者的多中心双盲、平行组、随机设计。患者对流涕和鼻塞症状进行评分,并在日记中记录长达7天的不良事件。患者还记录纸巾使用情况。五种试验治疗药物包括0.6毫克/毫升异丙托溴铵和1.0毫克/毫升赛洛唑啉;0.6毫克/毫升异丙托溴铵和0.5毫克/毫升赛洛唑啉;0.6毫克/毫升异丙托溴铵;1.0毫克/毫升赛洛唑啉;以及安慰剂溶液。

结果

共筛查864例患者,786例患者接受治疗。治疗1天后,安慰剂组与异丙托溴铵治疗组在流涕评分上有明显差异,安慰剂组与赛洛唑啉治疗组在鼻塞评分上有明显差异。异丙托溴铵/赛洛唑啉1.0和异丙托溴铵/赛洛唑啉0.5治疗在流涕方面均优于赛洛唑啉(p<0.0001),在鼻塞评分方面优于异丙托溴铵(p<0.001)。两种异丙托溴铵复方治疗的纸巾使用量均显著低于赛洛唑啉治疗组(p<0.0001)。除含血黏液、鼻出血、鼻道刺激和鼻干外,不良事件在各治疗组中分布均匀,这三种不良事件在接受含异丙托溴铵药物的三组中发生率较高。

结论

结果表明,异丙托溴铵和赛洛唑啉复方药物治疗普通感冒相关的流涕和鼻塞安全有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验